Indicator development programme
Open for comments Open until Request commenting lead permission
We have updated this service so that members of the same organisation can now collaborate on a joint online response.
Read our blog to learn more.
Contents
Pain: strong opioid use (osteoarthritis and chronic low back pain) 4
Pain: strong opioid use (MSK) 6
Pain: annual review long term opioid use 8
Diabetes: metformin and SGLT2 inhibitors (T2DM) 10
Diabetes: metformin and SGLT2 inhibitors (early onset T2DM) 12
Diabetes: metformin, SGLT2 inhibitors and semaglutide (T2DM and CVD) 14
How are you taking part in this consultation?
You will not be able to change how you comment later.
You must be signed in to answer questions